Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 45Leukemia 34Lymphoma, Non-Hodgkin 33Lymphoma 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Hematologic Neoplasms 20Breast Neoplasms 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 15Multiple Myeloma 13Neuroblastoma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Biphenotypic, Acute 11Central Nervous System Neoplasms 11Blast Crisis 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Dendritic Cell Sarcoma, Interdigitating 10Anemia, Refractory, with Excess of Blasts 10Recurrence 9Myeloproliferative Disorders 9Medulloblastoma 9Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9

Interventions

fludarabine 4fludarabine phosphate 3Cyclophosphamide 3thymoglobulin 1Whole-Body Irradiation 1Thiotepa 1Tacrolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mesna 1Melphalan 1Erythrocyte Count 1Dexamethasone 1Clofarabine 1Busulfan 1Bortezomib 1Blood Transfusion 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thalassemia × Thiotepa × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡